Active, not recruitingNCT03843255
Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy
Studying Dilated cardiomyopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Imperial College London
- Principal Investigator
- James WareImperial College London
- Intervention
- Part 1: DCM Cohort(other)
- Enrollment
- 2000 enrolled
- Eligibility
- 99 years · All sexes
- Timeline
- 2020 – 2029
Study locations (6)
- Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
- Glenfield Hospital, Leicester, United Kingdom
- Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, United Kingdom
- Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom
- Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
- Southampton General Hospital, Southampton, United Kingdom
Collaborators
British Heart Foundation · Royal Brompton & Harefield NHS Foundation Trust
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03843255 on ClinicalTrials.govOther trials for Dilated cardiomyopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07137338A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated CardiomyopathyRocket Pharmaceuticals Inc.
- ENROLLING BY INVITATIONNANCT07345338Mainstreaming Genetic Testing for Non-Ischemic Cardiomyopathy in Western CanadaThomas Roston
- RECRUITINGNCT07293338Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated CardiomyopathySecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGPHASE1NCT07241104A Study of AZD4063 in PLN R14del Dilated CardiomyopathyAstraZeneca
- RECRUITINGNANCT07359690Multimodal Analysis of Endomyocardial BiopsiesUniversity Hospital, Essen
- RECRUITINGPHASE1NCT06464588A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)Emory University
- RECRUITINGNANCT06922851Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGNCT06741995Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated CardiomyopathyUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology